Stay up to date on the latest oncology and nursing conferences.
The "Missing Link" in Hematopoietic Stem Cell Transplantation
September 27th 2016As clinical providers, the ability to meet the science of medicine with its physical, emotional, spiritual, and financial impact it has on patients is often unintentionally overlooked or, at the very least, minimized during the active treatment phase of care; therefore, the purpose and potential benefits that result from integrating palliative care early on in the process is missed.
Pick Up That Spade: The Therapeutic Effects of Gardening for Older Survivors
June 17th 2016As the number of older cancer survivors continues to grow, health researchers are looking for ways to combine healthy aging with healthy survivorship. It turns out that a relatively simple solution may be found in a survivor’s own backyard.
Amita Patel on the Benefits of a Multidisciplinary Care Team
May 12th 2016Amita Patel, NPC, Regional Cancer Care Associates, Central Jersey Division, talks about benefits of a multidisciplinary care team and some issues that providers should be aware of when treating patients undergoing chemotherapy.
Oral Chemotherapy Adherence: Monitoring for Better Outcomes
May 9th 2016In an effort to help ensure that patients are taking their oral anticancer medications and refilling their prescriptions, a team of four nurses and a physician from NYU Langone’s Laura & Isaac Perlmutter Cancer Center integrated a novel tracking workflow documentation system into the electronic health record.
Nurse-Led Resource Center Offers Precision Medicine Support for Patients and Families
May 5th 2016With genetic profiles and genomic targeting increasingly impacting treatment decisions, patients and families would welcome a one-stop place where they can find resources to help unravel all this complex information.
Moving Proactively to Support Patients With EGFR Inhibitor-Related Dermatologic AEs
May 1st 2016Developing a skin rash as a result of EGFR-inhibitor targeted therapy often signals that the drug is working, but for patients who experience these serious dermatologic adverse events, it may become so intolerable that they will scale back or even discontinue anticancer medications that could prolong their survival.